Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease

Keyphrases

• 4DCT 25%
• Ablative Therapy 25%
• Child B 50%
• Cirrhosis 25%
• Fiducial 25%
• Hepatic Failure 50%
• Hepatic Toxicity 25%
• Hepatocellular Carcinoma 100%
• Hepatocellular Carcinoma Patients 50%
• Isodose 50%
• Lesion number 25%
• Liver Disease 100%
• Liver Function 50%
• Local Control 25%
• Local Control Rate 50%
• Local Recurrence 25%
• Local Treatment 25%
• Non-hepatic 25%
• Oligometastatic 100%
• Overall Survival 75%
• Performance Status 25%
• Primary Liver Cancer 50%
• Stereotactic Body Radiation Therapy 100%
• Survival Rate 25%
• Treatment Options 50%
• Treatment Planning 25%

Medicine and Dentistry

• Ablation Therapy 16%
• Deterioration 16%
• Hepatocellular Carcinoma 100%
• Liver Cirrhosis 16%
• Liver Disease 100%
• Liver Failure 33%
• Liver Function 33%
• Liver Tumor 16%
• Local Therapy 16%
• Overall Survival 50%
• Recurrent Disease 16%
• Stereotactic Body Radiation Therapy 100%
• Survival Rate 16%
• Treatment Planning 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Deterioration 16%
• Liver Cell Carcinoma 100%
• Liver Cirrhosis 16%
• Liver Disease 100%
• Liver Failure 33%
• Liver Tumor 16%
• Overall Survival 50%
• Recurrent Disease 16%
• Survival Rate 16%